PT988861E - Formulacoes de proteina estabilizadas - Google Patents

Formulacoes de proteina estabilizadas

Info

Publication number
PT988861E
PT988861E PT99306262T PT99306262T PT988861E PT 988861 E PT988861 E PT 988861E PT 99306262 T PT99306262 T PT 99306262T PT 99306262 T PT99306262 T PT 99306262T PT 988861 E PT988861 E PT 988861E
Authority
PT
Portugal
Prior art keywords
protein formulations
stabilized protein
stabilized
formulations
protein
Prior art date
Application number
PT99306262T
Other languages
English (en)
Inventor
Peter Connor Canning
Barbara Jean Kamicker
Kasra Kasraian
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT988861E publication Critical patent/PT988861E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT99306262T 1998-08-17 1999-08-06 Formulacoes de proteina estabilizadas PT988861E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9687698P 1998-08-17 1998-08-17

Publications (1)

Publication Number Publication Date
PT988861E true PT988861E (pt) 2004-06-30

Family

ID=22259521

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99306262T PT988861E (pt) 1998-08-17 1999-08-06 Formulacoes de proteina estabilizadas

Country Status (17)

Country Link
US (1) US20050232898A1 (pt)
EP (1) EP0988861B1 (pt)
JP (1) JP3641170B2 (pt)
CN (1) CN1250282C (pt)
AR (1) AR016504A1 (pt)
AT (1) ATE260674T1 (pt)
AU (2) AU767431B2 (pt)
BR (1) BR9904150A (pt)
CA (1) CA2280449A1 (pt)
DE (1) DE69915204T2 (pt)
DK (1) DK0988861T3 (pt)
ES (1) ES2216447T3 (pt)
HK (1) HK1026151A1 (pt)
NZ (2) NZ510140A (pt)
PT (1) PT988861E (pt)
TW (1) TWI221773B (pt)
ZA (1) ZA995201B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60103940T2 (de) 2000-02-29 2005-07-28 Pfizer Products Inc., Groton Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
WO2002098445A1 (en) * 2001-05-30 2002-12-12 Chugai Seiyaku Kabushiki Kaisha Protein preparation
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
ITBA20020032A1 (it) * 2002-09-24 2004-03-25 Bio D Soc Metodo per stabilizzare le proteine per la conservazione ad alte temperature.
NZ543392A (en) * 2003-05-09 2009-02-28 Schering Ag Treatment of inflammatory respiratory diseases e.g. SARS, ARDS, IRDS
WO2005042024A1 (en) * 2003-11-04 2005-05-12 Lek Pharmaceuticals D.D. Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
EP1537876A1 (en) * 2003-12-01 2005-06-08 BioGeneriX AG Erythropoietin solution formulation
CA2545962A1 (en) * 2003-12-09 2005-07-07 Alcon, Inc. Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
RU2413530C9 (ru) * 2004-11-12 2021-05-18 Ново Нордиск А/С Стабильные препараты инсулинотропных пептидов
EP1787658B1 (en) * 2005-11-10 2012-03-14 CHEMI S.p.A. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
DE102006009437A1 (de) 2006-03-01 2007-09-13 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
JP5623743B2 (ja) 2006-10-20 2014-11-12 アムジエン・インコーポレーテツド 安定なポリペプチド製剤
EP2471510A1 (de) 2007-08-27 2012-07-04 BioGeneriX AG Flüssigformulierung von G-CSF
EP2197970B1 (en) * 2007-10-09 2011-07-20 Hercules Incorporated Crosslinkercontaining adhesive compositions
MX2011000859A (es) * 2008-07-23 2011-02-24 Ambrx Inc Polipeptidos g-csf bovinos modificados y sus usos.
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
GB2516808A (en) * 2013-05-31 2015-02-11 Innova Biosciences Ltd Antibody composition and buffer system therefor
US10500253B2 (en) 2015-01-05 2019-12-10 Cornell University Compositions and methods using IL-8 to improve milk production and reproductive health in mammals
US11464831B2 (en) 2015-01-05 2022-10-11 Cornell University Compositions and methods using IL-8 for improving health of mammals
EP3554257B1 (en) 2016-12-15 2023-07-12 Société des Produits Nestlé S.A. Compositions and methods that modulate white blood cells or neutrophils in a companion animal
EP3771463A1 (en) 2019-07-29 2021-02-03 Ludwig-Maximilians-Universität München Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances
CN116836920B (zh) * 2023-08-21 2024-05-24 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 一种无血清培养基及其制备间充质干细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
JPH0618781B2 (ja) * 1986-10-18 1994-03-16 中外製薬株式会社 感染症治療剤
ATE452190T1 (de) * 1988-05-13 2010-01-15 Amgen Inc Verfahren zur isolierung und reinigung von g-csf
US5013714A (en) * 1988-12-15 1991-05-07 Lindstrom Richard L Viscoelastic solution
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof

Also Published As

Publication number Publication date
AU4450199A (en) 2000-03-09
US20050232898A1 (en) 2005-10-20
CN1250282C (zh) 2006-04-12
DE69915204D1 (de) 2004-04-08
ES2216447T3 (es) 2004-10-16
EP0988861A1 (en) 2000-03-29
CN1250668A (zh) 2000-04-19
NZ510140A (en) 2005-01-28
ZA995201B (en) 2001-02-16
HK1026151A1 (en) 2000-12-08
EP0988861B1 (en) 2004-03-03
TWI221773B (en) 2004-10-11
DK0988861T3 (da) 2004-04-19
AU2004200568A1 (en) 2004-03-11
JP3641170B2 (ja) 2005-04-20
AU767431B2 (en) 2003-11-13
AR016504A1 (es) 2001-07-04
BR9904150A (pt) 2000-12-26
JP2000063264A (ja) 2000-02-29
NZ337258A (en) 2001-04-27
DE69915204T2 (de) 2004-07-29
CA2280449A1 (en) 2000-02-17
ATE260674T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
PT875252E (pt) Formulacoes de proteina c activada
CY2006006I1 (el) Πρωτεϊνικα σκευασματα
PT988861E (pt) Formulacoes de proteina estabilizadas
BR9914338B1 (pt) Formulação de xampu estabilizada
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
BR9710131A (pt) Formulações aquosas de peptideos
NO982097D0 (no) Peptider
NO982098L (no) Peptider
ID24289A (id) Benzotiazol inhibitor-inhibitor protein terosin kinase
DE59910409D1 (de) Distraktionsvorrichtung
ID23299A (id) Formulasi-formulasi farmasi
PT1130966E (pt) Formulacoes antiparasitarias
MA24473A1 (fr) Formulations
DE59912839D1 (de) Distraktionsvorrichtung
ID29635A (id) Formulasi mikrokapsul
ATE357237T1 (de) Formulierungen enthaltend cefuroxim-axetil
ID27655A (id) Formulasi mikrokapsul
ATE246494T1 (de) Brausezubereitungen
DE69925271D1 (de) Angiostatin-bindendes protein
ITMI972543A0 (it) Proteina p27bbp
ID26084A (id) Turunan-turunan amino antrasiklinon